RETRACTION: Combination Anti-CTLA-4 and Anti-RANKL in Metastatic Melanoma (Retraction of Vol 34, Pg E104, 2016)

被引:0
|
作者
Smyth
机构
关键词
D O I
10.1200/JCO.23.01358
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4448 / 4448
页数:1
相关论文
共 50 条
  • [31] Haemophagocytic lymphohistiocytosis as a complication of combination anti-PD-1 and anti-CTLA-4 checkpoint inhibitor immunotherapy for metastatic melanoma, and the outcome of rechallenge with single-agent anti-PD-1 immunotherapy
    Holmes, Zachary
    Courtney, Ashling
    Hiong, Alison
    BMJ CASE REPORTS, 2022, 15 (08)
  • [32] Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy'
    Imafuku, Keisuke
    Yoshino, Koji
    Yamaguchi, Kei
    Tsuboi, Satoshi
    Ohara, Kuniaki
    Hata, Hiroo
    BRITISH JOURNAL OF CANCER, 2017, 116 (08) : e14 - e14
  • [33] Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’
    Keisuke Imafuku
    Koji Yoshino
    Kei Yamaguchi
    Satoshi Tsuboi
    Kuniaki Ohara
    Hiroo Hata
    British Journal of Cancer, 2017, 116 : e14 - e14
  • [34] Abscopal Effect in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors (Anti-CTLA-4 and Anti-PD1): A Retrospective Analysis of a Single Institution
    Carvalho, R. F.
    Ferrigno, R.
    Marotta, R. C.
    Amarantes, M. P. F.
    Schmerling, R. A.
    Haddad, C. K.
    Gil, E.
    Moraes, P. L.
    Zanuncio, P. H.
    Buzaid, A. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S159 - S159
  • [35] Efficacy and toxicity of treatment with the anti-CTLA-4 antibody Ipilimumab in patients with metastatic melanoma who have progressed on anti-PD-1 therapy
    Prithviraj, Prashanth
    McArthur, Grant A.
    Atkinson, Victoria
    Parente, Phillip
    Andrews, Miles Cameron
    Parakh, Sagun
    Cebon, Jonathan S.
    Klein, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] RETRACTION: Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma (Retraction of Vol 392, Pg 551, 2019)
    Wang, Luping
    Wang, Junyu
    Zhao, Hong
    Jiang, Guoping
    Feng, Xiaojie
    Sui, Wenxia
    Liu, Hongling
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (03) : 569 - 569
  • [37] RETRACTION: Bilateral pneumonectomy with difficult airway managed by using a combination of I-Gel and EZ-Blocker (Retraction of Vol 34, Pg 516, 2016)
    Ueshima, Hironobu
    Otake, Hiroshi
    JOURNAL OF CLINICAL ANESTHESIA, 2022, 79
  • [38] The price of tumor control: An analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network
    Heinzerling, L.
    Goldinger, S. M.
    Voskens, C. J.
    Loquai, C.
    Robert, C.
    Berking, C.
    Eigentler, T.
    Fluck, M.
    Garbe, C.
    Gutzmer, R.
    Gleiss, H.
    Hauschild, A.
    Hein, R.
    Justich, A.
    Keller, U.
    Klein, C.
    Mateus, C.
    Mohr, P.
    Paetzold, S.
    Satzger, I
    Schadendorf, D.
    Schlaeppi, M.
    Ulrich, J.
    Vaubel, J.
    von Moos, R.
    Weder, P.
    Wilhelm, T.
    Kaehler, K.
    Goeppner, D.
    Dummer, R.
    Schuler, G.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 89 - 89
  • [39] Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti-CTLA-4 Antibody Therapy
    Bronstein, Yulia
    Ng, Chaan S.
    Hwu, Patrick
    Hwu, Wen-Jen
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 197 (06) : W992 - W1000
  • [40] The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
    Voskens, Caroline J.
    Goldinger, Simone M.
    Loquai, Carmen
    Robert, Caroline
    Kaehler, Katharina C.
    Berking, Carola
    Bergmann, Tanja
    Bockmeyer, Clemens L.
    Eigentler, Thomas
    Fluck, Michael
    Garbe, Claus
    Gutzmer, Ralf
    Grabbe, Stephan
    Hauschild, Axel
    Hein, Ruediger
    Hundorfean, Gheorghe
    Justich, Armin
    Keller, Ullrich
    Klein, Christina
    Mateus, Christine
    Mohr, Peter
    Paetzold, Sylvie
    Satzger, Imke
    Schadendorf, Dirk
    Schlaeppi, Marc
    Schuler, Gerold
    Schuler-Thurner, Beatrice
    Trefzer, Uwe
    Ulrich, Jens
    Vaubel, Julia
    von Moos, Roger
    Weder, Patrik
    Wilhelm, Tabea
    Goeppner, Daniela
    Dummer, Reinhard
    Heinzerling, Lucie M.
    PLOS ONE, 2013, 8 (01):